Process for the stereoselective preparation of a pyrazole-carboxamide

US9637457B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9637457-B2
Application numberUS-201414892386-A
CountryUS
Kind codeB2
Filing dateJun 19, 2014
Priority dateJun 26, 2013
Publication dateMay 2, 2017
Grant dateMay 2, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a process for the enantioselective preparation of the compound of formula (Ib), which process comprises a) reducing the (E)- or (Z)-form of a compound of formula (II), with an enantioselective reagent to a compound of formula (IIIa), and b) acylating the compound of formula (IIIa) with the compound of formula (IV), or c) coupling the compound of formula (IV) with the compound of formula (II), to give a compound of formula (V) and d) reducing compound of formula (V) in the presence of hydrogen, a catalyst and a chiral ligand, to the compound of formula (Ib).

First claim

Opening claim text (preview).

What is claimed is: 1. A process for the enantioselective preparation of the compound of formula (Ib) which process comprises a) reducing the (E)- or (Z)-form of a compound of formula (II) with an enantioselective reagent to give a compound of formula (IIIa) and b) acylating the compound of formula (IIIa) with the compound of formula (IV) or c) coupling the compound of formula (IV) with the compound of formula (II), to give a compound of formula (V) and d) reducing the compound of formula (V) in the presence of hydrogen, a catalyst and a chiral ligand, to give the compound of formula (Ib). 2. The process for the enantioselective preparation of the compound of formula (Ib) according to claim 1 , which process comprises a) reducing the (E)- or (Z)-form of a compound of formula (II) with an enantioselective reagent to a compound of formula (IIIa) and b) acylating the compound of formula (IIIa) with the compound of formula (IV) 3. The process for the enantioselective preparation of the compound of formula (Ib) according to claim 1 , which process comprises c) coupling the compound of formula (IV) with the compound of formula (II), to give a compound of formula (V) and d) reducing the compound of formula (V) in the presence of hydrogen, a catalyst and a chiral ligand, to the compound of formula (Ib). 4. The process for the enantioselective preparation of the compound of formula (Ib) according to claim 1 , which process comprises a) reducing the (E)- or (Z)-form of a compound of formula (II) with a borane complex as a reducing agent, in the presence of a single enantiomer of a chiral 1,2-amino-alcohol, in an inert solvent and at temperatures ranging from 0° C. and 60° C., to a compound of formula (IIIa) and b) acylating the compound of formula (IIIa) with the compound of formula (IV), in an inert solvent, in the presence of a weak base and at temperatures ranging between −20° C. and 120° C. or c) coupling the compound of formula (IV) with the compound of formula (II), by deprotonation of compound of formula (II) with 1 to 5 equivalents of a suitable base in an inert aprotic solvent, wherein the suitable base is selected from KN(iPr) 2 , LiN(iPr) 2 , KN(trimethylsilyl) 2 , BuLi, and KN(iPr) 2 /KOtBu, at temperature ranging from −78° C. to 25° C., followed by treatment with compound of formula (IV), to give a compound of formula (V), and d) reducing the compound of formula (V) in the presence of hydrogen at pressures ranging from 0.1 bar to 15 MPa, in the presence of 0.1 to 0.0001 equivalent of a metal catalyst and a single enantiomer of a suitable chiral ligand, in ratio of metal catalyst to chiral ligand ranging from 0.8 to 1.5, in a suitable solvent and at temperatures ranging from 20° C. to 100° C., to give the compound of formula (Ib). 5. The compound of formula (V) 6. The process of claim 2 , wherein the reduction of the compound of formula (II) is performed via the action of borane in the presence of a single enantiomer of a chiral amino-alcohol. 7. The process according to claim 6 , wherein the source of borane is borane diethylaniline.

Assignees

Inventors

Classifications

  • C07D231/14Primary

    with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title

  • having oxygen atoms of hydroxylamino groups etherified · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9637457B2 cover?
The present invention relates to a process for the enantioselective preparation of the compound of formula (Ib), which process comprises a) reducing the (E)- or (Z)-form of a compound of formula (II), with an enantioselective reagent to a compound of formula (IIIa), and b) acylating the compound of formula (IIIa) with the compound of formula (IV), or c) coupling the compound of formula (IV) wit…
Who is the assignee on this patent?
Syngenta Participations Ag
What technology area does this patent fall under?
Primary CPC classification C07D231/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).